| Caption | Chairman and CEO of CanSino BIO Yu Xuefeng (front row left) and Pfizer China Chief Operating Officer Wu Kun (right) signed a promotional service agreement |
| Source | CanSino Biologics Inc |
| Download | |
| Related Press Releases Links |
康希諾生物與輝瑞簽署有望獲批的四價腦膜炎球菌結合疫苗推廣服務協議 |